HeartSciences shares jump 11.97% after-hours as Ascendiant Capital raises price target to $9.20 with maintained "Buy" rating.

HeartSciences (NASDAQ:HSCS) surged 11.97% in after-hours trading following an updated analyst rating from Ascendiant Capital. Analyst Lucas Ward maintained a "Buy" recommendation for the stock while raising the price target from $9.00 to $9.20, reflecting a 2.22% increase in potential upside. The upgraded target, based on the firm's confidence in the company’s outlook, likely spurred investor optimism and post-market buying activity. The move aligns with the analyst’s reinforced positive stance, which directly supports the stock’s upward trajectory.